Emerald Advisers’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Emerald Advisers’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-291,936	Closed	-$5.49M	–	309
2020 Q4	$5.49M	Sell	291,936 -57,980	-17%	-$1.25M	0.18%	118
2020 Q3	$7.39M	Buy	349,916 +65,431	+23%	+$1.53M	0.3%	99
2020 Q2	$8.22M	Buy	284,485 +57,604	+25%	+$1.74M	0.36%	97
2020 Q1	$7.94M	Sell	226,881 -147,123	-39%	-$4.76M	0.46%	80
2019 Q4	$9.14M	Buy	+374,004	New	+$6.56M	0.39%	96

Other funds holding OYST

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

VVA

Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Emerald Advisers's OYST Position: Q1 2021 in Review

Emerald Advisers sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2021, closing a stake of 291,936 shares — an estimated $5.49M sold.

Emerald Advisers first reported a position in OYST in Q4 2019 and held it in 5 quarters. The position peaked at $9.14M in Q4 2019. 61 funds tracked by Wall St. Rank hold OYST as of Q1 2021.

Emerald Advisers reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Emerald Advisers sold 291,936 Oyster Point Pharma, Inc. Common Stock shares in Q1 2021, an estimated $5.49M.
Emerald Advisers first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2019 and held it in 5 quarters.
Emerald Advisers's Oyster Point Pharma, Inc. Common Stock position peaked at $9.14M in Q4 2019.
61 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2021.

Based on Emerald Advisers's 13F filing for Q1 2021, filed 29 Apr 2021.